Viagen

Warhound Raises $200 Million to Genetically Engineer Military Working Dogs

Warhound, backed by Sequoia, 8VC, Corner Ventures and In-Q-Tel at a $1.2 billion valuation, plans to clone and genetically edit Belgian Malinois and German Shepherd cell lines to supply the U.S. military and law enforcement.